KR20190113371A - Composition for skin-whitening and anti-winkle comprising extract of Poria cocos, Coix lachrymajobi and Stachys sieboldii fermented using Hericium erinaceum mycelium as effective component - Google Patents
Composition for skin-whitening and anti-winkle comprising extract of Poria cocos, Coix lachrymajobi and Stachys sieboldii fermented using Hericium erinaceum mycelium as effective component Download PDFInfo
- Publication number
- KR20190113371A KR20190113371A KR1020180035957A KR20180035957A KR20190113371A KR 20190113371 A KR20190113371 A KR 20190113371A KR 1020180035957 A KR1020180035957 A KR 1020180035957A KR 20180035957 A KR20180035957 A KR 20180035957A KR 20190113371 A KR20190113371 A KR 20190113371A
- Authority
- KR
- South Korea
- Prior art keywords
- fermentation extract
- extract
- fermentation
- yulmu
- weight
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 135
- 239000000203 mixture Substances 0.000 title claims abstract description 93
- 244000077995 Coix lacryma jobi Species 0.000 title abstract description 5
- 235000007354 Coix lacryma jobi Nutrition 0.000 title abstract description 5
- 244000197580 Poria cocos Species 0.000 title abstract description 5
- 235000008599 Poria cocos Nutrition 0.000 title abstract description 5
- 244000057214 Stachys sieboldii Species 0.000 title abstract description 5
- 235000005116 Stachys sieboldii Nutrition 0.000 title abstract description 5
- 240000000588 Hericium erinaceus Species 0.000 title abstract 2
- 235000007328 Hericium erinaceus Nutrition 0.000 title abstract 2
- 239000002537 cosmetic Substances 0.000 claims abstract description 27
- 230000002087 whitening effect Effects 0.000 claims abstract description 25
- 230000037303 wrinkles Effects 0.000 claims abstract description 20
- 239000004480 active ingredient Substances 0.000 claims abstract description 19
- 238000002156 mixing Methods 0.000 claims abstract description 16
- 238000000855 fermentation Methods 0.000 claims description 106
- 230000004151 fermentation Effects 0.000 claims description 106
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 36
- 241000233866 Fungi Species 0.000 claims description 16
- 230000006872 improvement Effects 0.000 claims description 11
- 239000002609 medium Substances 0.000 claims description 11
- 235000013376 functional food Nutrition 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 10
- 230000036541 health Effects 0.000 claims description 9
- 239000004615 ingredient Substances 0.000 claims description 9
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 238000003809 water extraction Methods 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 4
- 239000001963 growth medium Substances 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- 229910021536 Zeolite Inorganic materials 0.000 claims description 3
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 239000010457 zeolite Substances 0.000 claims description 3
- 240000008866 Ziziphus nummularia Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 20
- 235000013402 health food Nutrition 0.000 abstract description 2
- 230000037331 wrinkle reduction Effects 0.000 abstract 2
- 210000003491 skin Anatomy 0.000 description 41
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 18
- 230000002401 inhibitory effect Effects 0.000 description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 15
- -1 pack Substances 0.000 description 14
- 239000006210 lotion Substances 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 239000006071 cream Substances 0.000 description 11
- 238000009472 formulation Methods 0.000 description 10
- 241000282988 Capreolus Species 0.000 description 8
- 241000254173 Coleoptera Species 0.000 description 8
- 102000029816 Collagenase Human genes 0.000 description 8
- 108060005980 Collagenase Proteins 0.000 description 8
- 229960002424 collagenase Drugs 0.000 description 8
- 235000013305 food Nutrition 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 6
- 238000007792 addition Methods 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 5
- 208000003351 Melanosis Diseases 0.000 description 5
- 102000016387 Pancreatic elastase Human genes 0.000 description 5
- 108010067372 Pancreatic elastase Proteins 0.000 description 5
- 102000003425 Tyrosinase Human genes 0.000 description 5
- 108060008724 Tyrosinase Proteins 0.000 description 5
- 238000002835 absorbance Methods 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 235000016709 nutrition Nutrition 0.000 description 5
- 230000035764 nutrition Effects 0.000 description 5
- 239000001965 potato dextrose agar Substances 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 235000013343 vitamin Nutrition 0.000 description 5
- 239000011782 vitamin Substances 0.000 description 5
- 229940088594 vitamin Drugs 0.000 description 5
- 229930003231 vitamin Natural products 0.000 description 5
- MKMCJLMBVKHUMS-UHFFFAOYSA-N Coixol Chemical compound COC1=CC=C2NC(=O)OC2=C1 MKMCJLMBVKHUMS-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 150000001720 carbohydrates Chemical class 0.000 description 4
- 235000014633 carbohydrates Nutrition 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 238000012790 confirmation Methods 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- 239000000686 essence Substances 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 230000008099 melanin synthesis Effects 0.000 description 4
- 230000003061 melanogenesis Effects 0.000 description 4
- 239000007921 spray Substances 0.000 description 4
- 230000001256 tonic effect Effects 0.000 description 4
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 206010014970 Ephelides Diseases 0.000 description 3
- 241000237858 Gastropoda Species 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- 235000010323 ascorbic acid Nutrition 0.000 description 3
- 239000011668 ascorbic acid Substances 0.000 description 3
- 230000003833 cell viability Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 210000002510 keratinocyte Anatomy 0.000 description 3
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 3
- 229960004705 kojic acid Drugs 0.000 description 3
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 210000002752 melanocyte Anatomy 0.000 description 3
- 239000000419 plant extract Substances 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- QFPLAAZRZNKRRY-GIICLEHTSA-N (2r)-2-[(3s,5r,10s,13r,14r,17r)-3-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1h-cyclopenta[a]phenanthren-17-yl]-6-methylhept-5-enoic acid Chemical compound CC1(C)[C@@H](O)CC[C@]2(C)C3=CC[C@]4(C)[C@@H]([C@@H](CCC=C(C)C)C(O)=O)CC[C@@]4(C)C3=CC[C@H]21 QFPLAAZRZNKRRY-GIICLEHTSA-N 0.000 description 2
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical group C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 229940123457 Free radical scavenger Drugs 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 241001248610 Ophiocordyceps sinensis Species 0.000 description 2
- 208000012641 Pigmentation disease Diseases 0.000 description 2
- 206010035664 Pneumonia Diseases 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 150000001746 carotenes Chemical class 0.000 description 2
- 235000005473 carotenes Nutrition 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 239000004088 foaming agent Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- JEGUKCSWCFPDGT-UHFFFAOYSA-N h2o hydrate Chemical compound O.O JEGUKCSWCFPDGT-UHFFFAOYSA-N 0.000 description 2
- 239000011121 hardwood Substances 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 229940069445 licorice extract Drugs 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 2
- 239000002417 nutraceutical Substances 0.000 description 2
- 235000021436 nutraceutical agent Nutrition 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 210000000496 pancreas Anatomy 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 230000019612 pigmentation Effects 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000002516 radical scavenger Substances 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 2
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 230000036556 skin irritation Effects 0.000 description 2
- 231100000475 skin irritation Toxicity 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000000516 sunscreening agent Substances 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- XHSWVNQODRKABJ-UHFFFAOYSA-N 2,7-dinitroindazole Chemical compound [O-][N+](=O)C1=CC=CC2=CN([N+]([O-])=O)N=C12 XHSWVNQODRKABJ-UHFFFAOYSA-N 0.000 description 1
- WLJYNHBZKOQNNI-UHFFFAOYSA-N 5-(diaminomethylideneamino)-2-[[1-[2-[[4-methyl-2-[[1-[(4-phenyldiazenylphenyl)methoxycarbonyl]pyrrolidine-2-carbonyl]amino]pentanoyl]amino]acetyl]pyrrolidine-2-carbonyl]amino]pentanoic acid Chemical compound C1CCC(C(=O)NC(CCCN=C(N)N)C(O)=O)N1C(=O)CNC(=O)C(CC(C)C)NC(=O)C1CCCN1C(=O)OCC(C=C1)=CC=C1N=NC1=CC=CC=C1 WLJYNHBZKOQNNI-UHFFFAOYSA-N 0.000 description 1
- HOMSOWZTBJWNHP-UHFFFAOYSA-N 5-chlorothiadiazole Chemical compound ClC1=CN=NS1 HOMSOWZTBJWNHP-UHFFFAOYSA-N 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 235000016068 Berberis vulgaris Nutrition 0.000 description 1
- 241000335053 Beta vulgaris Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 244000132059 Carica parviflora Species 0.000 description 1
- 235000014653 Carica parviflora Nutrition 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- DPQCZNIGGNJGTD-UHFFFAOYSA-N Chloride-(??)-2-Methylpentanoic acid Natural products CCCCCCC=CCCCCCCCCCC(=O)OC(C)C(C)OC(=O)CCCCCCCC=CCCCCCC DPQCZNIGGNJGTD-UHFFFAOYSA-N 0.000 description 1
- 241000675108 Citrus tangerina Species 0.000 description 1
- DPQCZNIGGNJGTD-MVCBGFDASA-N Coixenolide Chemical compound CCCCCC\C=C\CCCCCCCCCC(=O)O[C@@H](C)[C@@H](C)OC(=O)CCCCCCC\C=C/CCCCCC DPQCZNIGGNJGTD-MVCBGFDASA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- AHMIDUVKSGCHAU-UHFFFAOYSA-N Dopaquinone Natural products OC(=O)C(N)CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-UHFFFAOYSA-N 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 240000007108 Fuchsia magellanica Species 0.000 description 1
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 1
- 241000123222 Hericium Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- AHMIDUVKSGCHAU-LURJTMIESA-N L-dopaquinone Chemical compound [O-]C(=O)[C@@H]([NH3+])CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-LURJTMIESA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 235000003228 Lactuca sativa Nutrition 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 240000000599 Lentinula edodes Species 0.000 description 1
- 235000001715 Lentinula edodes Nutrition 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000361919 Metaphire sieboldi Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 241001061526 Pluteus cervinus Species 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 240000006794 Volvariella volvacea Species 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 244000126002 Ziziphus vulgaris Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000003915 air pollution Methods 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- HOWJQLVNDUGZBI-UHFFFAOYSA-N butane;propane Chemical compound CCC.CCCC HOWJQLVNDUGZBI-UHFFFAOYSA-N 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003518 caustics Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000007799 cork Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 229940097362 cyclodextrins Drugs 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- QFPLAAZRZNKRRY-UHFFFAOYSA-N dehydrotrametenolic acid Natural products CC1(C)C(O)CCC2(C)C3=CCC4(C)C(C(CCC=C(C)C)C(O)=O)CCC4(C)C3=CCC21 QFPLAAZRZNKRRY-UHFFFAOYSA-N 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000002849 elastaseinhibitory effect Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 229940096118 ella Drugs 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229960004337 hydroquinone Drugs 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical class C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 210000002780 melanosome Anatomy 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 208000030247 mild fever Diseases 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100001083 no cytotoxicity Toxicity 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229940124595 oriental medicine Drugs 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- VDYCLYGKCGVBHN-UHFFFAOYSA-N pachymaic acid Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC(=C)C(C)C)C(O)=O)C(O)CC21C VDYCLYGKCGVBHN-UHFFFAOYSA-N 0.000 description 1
- SRDNLMOBFKJOSD-UHFFFAOYSA-N pachymic acid Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C(O)=O)C(O)CC21C SRDNLMOBFKJOSD-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- DGMKFQYCZXERLX-UHFFFAOYSA-N proglumide Chemical compound CCCN(CCC)C(=O)C(CCC(O)=O)NC(=O)C1=CC=CC=C1 DGMKFQYCZXERLX-UHFFFAOYSA-N 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 229940071089 sarcosinate Drugs 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- OOLLAFOLCSJHRE-ZHAKMVSLSA-N ulipristal acetate Chemical compound C1=CC(N(C)C)=CC=C1[C@@H]1C2=C3CCC(=O)C=C3CC[C@H]2[C@H](CC[C@]2(OC(C)=O)C(C)=O)[C@]2(C)C1 OOLLAFOLCSJHRE-ZHAKMVSLSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/208—Fungi extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Abstract
Description
본 발명은 노루궁뎅이버섯 균사체를 이용한 백복령 발효 추출물, 율무 발효 추출물 및 초석잠 발효 추출물의 혼합물을 유효성분으로 함유하는 피부 미백 및 주름 개선용 조성물에 관한 것이다.The present invention relates to a composition for improving skin whitening and wrinkles containing a mixture of Baekbokyeong fermentation extract, Yulmu fermentation extract and Choseok nap fermentation extract using the Roe mushroom fungus mycelium as an active ingredient.
피부는 신체조직 중 직접적으로 외부환경에 노출되어 있으며, 인체의 내부와 외부환경 사이의 방어벽 역할을 하여 화학물질이나 자외선을 포함한 외부 환경오염 물질 및 미생물의 침입을 방어함으로써 주위환경으로부터 생체를 보호한다. 또한 피부는 멜라닌, 헤모글로빈(hemoglobin), 카로틴(carotene) 등에 의해 색이 결정되는데 이 중에서도 멜라닌이 가장 중요한 역할을 한다. 멜라닌은 사람의 피부색을 결정하는 것 이외에도 자외선 흡수 작용, 자유 라디칼 소거제(free radical scavenger) 등과 같은 피부 보호 작용을 수행한다. 그러나 자외선의 과다 노출, 대기 오염, 스트레스 등과 같은 외부의 환경 변화에 의하여 멜라닌이 과다하게 생성되면 피부 내에서 색소 침착 현상을 일으켜 피부의 흑화(melanism) 또는 기미, 주근깨 등의 원인이 된다. 피부의 흑화는 내적 및 외적 요인에 대한 피부 세포의 반응에 의하여 발생하는 것으로, 대표적인 요인은 자외선 노출로 인한 것이다. 즉, 피부가 자외선에 노출되면 티로시나아제(tyrosinase)가 활성화되는데, 상기 티로시나아제가 피부조직에 존재하는 티로신에 작용하여 도파(DOPA) 및 도파퀴논(dopaquinone)을 생성시키는 산화 과정에 의하여, 피부 색소 세포인 멜라노사이트(melanocyte) 내의 멜라노좀(melanosome)에서 멜라닌이라는 중합체가 합성되며, 이러한 멜라닌이 피부의 각질 형성 세포인 케라티노사이트(keratinocyte)로 전달되고 각질화 과정에 의해 피부 표면에 도달하여 자외선으로부터 피부를 보호하게 된다. 따라서, 멜라닌은 우리 인체에 없어서는 안되는 자외선 방어제이며, 또한 단백질, 지질, 핵산 등과 같은 생체성분을 변형시키는 다양한 라디칼을 제거하는 효과적인 자유 라디칼 소거제의 역할을 담당하고 있다. 그러나 멜라닌이 국소적으로 과도하게 합성되거나, 피부 병변 및 노화에 따른 피부의 생리 기능이 떨어지게 되면, 멜라닌이 피부 표면에 침착되어 기미, 주근깨 및 다양한 색소 침착을 유발하게 된다. 상기한 바와 같이 피부 흑화의 원인과 기작이 밝혀지면서, 미백 화장료의 제조에 있어 피부 흑화 과정에 관여하는 효소인 티로시나아제의 활성 저해 효과를 갖는 물질들을 화장료에 배합하거나, 또는 멜라닌 생성 과정 중에서 일부 반응을 저해함으로써 멜라닌의 생성을 감소시키는 방법이 일반적으로 사용되고 있다. 이러한 목적을 위해 사용되고 있는 대표적인 물질로는 아스코르브산(ascorbic acid), 코지산(kojic acid), 하이드로퀴논(hydroquinone) 등의 화학 물질과 상백피 추출물, 감초 추출물 등의 식물 추출물이 있다. 하지만, 아스코르브산은 티로시나아제 활성 저해 효과가 부족할 뿐만 아니라 분자 자체의 안정성이 낮아서 멜라닌 생성 억제제로 적합하지 않으며, 코지산은 티로시나아제의 저해활성이 우수하지만, 화장료에 배합할 때 변색되고 경시 변화에 따라서 역가가 저하되는 등의 안정성에 문제가 있을 뿐만 아니라, 피부 자극이 커서 사용상 한계가 있고, 하이드로퀴논은 피부 자극 및 안전성 문제로 인하여 화장료에서의 사용이 제한되고 있다. 따라서, 신규하고 효과적인 미백 성분의 개발에 대한 관심이 집중되고 있다.The skin is directly exposed to the external environment among the body tissues, and acts as a barrier between the internal and external environment of the human body, protecting the living body from the surrounding environment by preventing the invasion of external environmental pollutants and microorganisms including chemicals and ultraviolet rays . In addition, the skin color is determined by melanin, hemoglobin (hemoglobin), carotene (carotene), among which melanin plays the most important role. In addition to determining human skin color, melanin performs skin protection such as ultraviolet absorption and free radical scavenger. However, excessive production of melanin due to external environmental changes such as overexposure to UV rays, air pollution, and stress causes pigmentation in the skin, causing melanism, blemishes, and freckles. Blackening of the skin is caused by the response of skin cells to internal and external factors, a representative factor being due to UV exposure. That is, when the skin is exposed to ultraviolet light, tyrosinase is activated, and the tyrosinase acts on tyrosine present in the skin tissue to produce dopa (DOPA) and dopaquinone. In the melanocytes of the skin pigment cells melanocytes (melanosome) is synthesized a polymer called melanin, which is transferred to the keratinocytes (keratinocyte), the keratinocytes of the skin and reaches the skin surface by the keratinization process It protects the skin from ultraviolet rays. Therefore, melanin is an indispensable UV protective agent in the human body, and also serves as an effective free radical scavenger that removes various radicals that modify biological components such as proteins, lipids, nucleic acids, and the like. However, if the melanin is locally excessively synthesized or the skin's physiological function decreases due to skin lesions and aging, melanin is deposited on the skin surface, causing melasma, freckles and various pigmentation. As mentioned above, the cause and mechanism of skin blackening are revealed, and a substance which has an inhibitory effect of tyrosinase, an enzyme involved in the skin blackening process in the manufacture of a whitening cosmetic, is incorporated into the cosmetic, or part of the melanin production process. Methods for reducing the production of melanin by inhibiting the reaction are generally used. Representative materials used for this purpose include chemicals such as ascorbic acid, kojic acid, hydroquinone and plant extracts such as lettuce extract and licorice extract. However, ascorbic acid lacks the inhibitory effect of tyrosinase activity and is not suitable as an inhibitor of melanin production due to the low stability of the molecule itself, while kojic acid is excellent in inhibiting activity of tyrosinase, but discolored when combined with cosmetics, Therefore, not only there is a problem in stability, such as lowering the titer, the skin irritation is large, there is a limit in use, hydroquinone is limited to use in cosmetics due to skin irritation and safety problems. Therefore, attention is focused on the development of new and effective whitening ingredients.
한편, 백복령(Poria cocos)은 베어 낸 지 여러 해 지난 소나무뿌리에 기생하여 혹처럼 자라는 것으로 속이 흰 것은 백복령이라 하고 분홍빛인 것은 적복령이라고 한다. 약효가 있는 약용작물로서 식품보다는 약재로의 쓰임새가 많았으나 동의보감에 의하면 곡식을 먹지 않아도 배가 고프지 않게 한다고 되어 있는 것을 보면 구황식품으로 이용하기도 하였을 것이다. 동의보감에 의하면 백복령의 맛은 달고 심심하며 성질이 평(平)하여 보(補)하는 작용이 있다고 한다. 그리하여 옛부터 강장제로 많이 사용되었으며 병 후 회복에도 이용하였다. 백복령의 주성분은 베타-파키만(β-Pachyman)이 함유되어 있고, 건조 중량의 약 93%를 차지한다. 트리테르페노이드(Triterpenoid) 화합물이 파킴산(Pachymic acid), 투물로스산(Tumulosic acid), 3-베타-히드록실라노스타-7,9(11),24-트리엔-21-오익산(3-β-Hydroxylanosta-7,9(11),24-trien-21-oic acid)을 함유한다. 이외에도 키틴(Chitin), 단백질, 지방, 스테롤(Sterol), 레시틴(Lecithin), 글루코오스(Glucose), 아데닌(Adenin), 히스티딘(Histidine), 콜린(Choline), 베타-파키만(β-Pachyman) 분해효소, 리파아제(Lipase), 프로테아제(Protease) 등이 함유되어 있다. 암 억제, 위장, 강장, 췌장, 신장에 탁월한 효능을 보이고 있다. 옛날부터 강장제로 사용되었다. 폐경(肺經)·비경(脾經)·심경(心經)·신경(腎經)·방광경(膀胱經)에 작용하여 비장을 보하고 가래를 삭이며 정신을 안정시킨다. 약리실험 결과에 의하면 이뇨작용과 혈당량을 낮추는 작용, 진정작용 등을 하는 것으로 밝혀졌으며 면역 부활작용을 하는 것으로도 알려져 있다.On the other hand, Poria cocos is said to grow in the shape of a hump from the roots of pine trees many years after cutting it. As a medicinal crop with medicinal effects, it was used as a medicinal herb rather than a food, but according to the agreement, it would have been used as a vulcanized food if it was said that it would not make you hungry without eating grain. According to Dongbogam, the taste of Baekbokyeong is sweet, boring, and flat. Thus, it has been used a lot as a tonic since ancient times and also used for recovery after illness. The main component of the Baekbokryeong contains beta-Pachyman and accounts for about 93% of the dry weight. Triterpenoid compounds include pachymic acid, tumulusic acid, 3-beta-hydroxylanosta-7,9 (11), 24-triene-21-oic acid (3-β-Hydroxylanosta-7,9 (11), 24-trien-21-oic acid). Chitin, Protein, Fat, Sterol, Lecithin, Glucose, Adenin, Histidine, Choline, Beta-Pachman Degradation Enzymes, Lipase, Protease, etc. are contained. It has excellent effects on cancer suppression, stomach, tonic, pancreas and kidney. It has been used as a tonic since ancient times. It works on menopause, parenteral, heart, nerve, and bladder to protect the spleen, sputum, and stabilize the mind. The results of pharmacological experiments have been shown to act as a diuretic, lowering blood sugar, sedation, and also known as an immune resurrection.
율무(Coix lachrymajobi)는 차로도 끓여 마실 수 있는 곡식의 한 종류로 누구나 쉽게 접할 수 있으며 한의학에서는 의이인(薏苡仁)이라는 이름으로 사용하고 있는 약재의 한 종류이다. 한방에서는 피부에 좋은 식품으로 제일 먼저 율무를 꼽는다. 민간에서는 산후에 갑자기 주근깨가 늘어나면 날마다 율무죽을 쑤어 먹이기도 했다. ‘본초강목’에 따르면, 율무는‘비장을 튼튼하게 해준다’고 되어있다. 율무에 들어 있는 코이키세놀라이드(coixenolide) 성분은 항암 작용을 하며, 또 뿌리에 함유된 코익솔(coixol)은 진통, 진정, 해열 효과가 인정된다는 연구결과도 있다. 이는 코익솔의 항염 작용, 활성산소를 제거하는 항산화 작용, 항알레르기 작용및 항히스타민 작용과 관련이 있는 것으로 알려져 있다. Coix lachrymajobi ) is a kind of grain that can be boiled and drinked by tea, and is easily accessible to anyone. It is a kind of medicinal herb used in the name of Uiin in Korean medicine. In oriental medicine, Yulmu is the first food that is good for skin. In the private sector, if the freckles suddenly increase after giving birth, they also ate yulmujuk every day. According to the Herb Tree, Yulmu is 'strengthening the spleen'. Coixenolide contained in Yulmu has anti-cancer effects, and there is research showing that coixol in roots has analgesic, calming and antipyretic effects. It is known that it is related to the anti-inflammatory action of COIXOL, antioxidant action to remove free radicals, antiallergic action and antihistamine action.
초석잠(Stachys sieboldii miq.)은 꿀풀과에 속하는 다년생 초본식물로 높이는 30~60cm로 자란다. 꽃은 자홍색이고 5월 중순 무렵부터 8월까지 가지와 줄기의 윗부분에 돌아가며 층층으로 핀다. 뿌리 부위는 구근처럼 보이는 괴경 부분으로 길이가 1~3cm로 고동모양이다. 뿌리 부위는 말갛고 우유빛을 띤다. 다른 이름으로 감로자, 적로, 감로아, 지잠, 토충초, 지고우초, 지유, 토용, 보탑채, 와아채 등으로 불린다. 효능으로는 해열, 해수, 폐렴, 태독, 활혈, 하혈, 종기, 염증, 진통, 경풍, 맹장염, 인후통, 미열, 붓기 등에 효과가 있는 것으로 알려져 있으며, 특히 최근에는 페닐에타노이드 배당체가 근무력증, 뇌경색, 노인성 치매 예방 및 기억력 증진에 효과가 있다고 알려져 있다. Stachys sieboldii miq.) is a perennial herbaceous plant belonging to the Lamiaceae family and grows up to 30 ~ 60cm in height. Flowers are fuchsia and bloom in layers, from the middle of May to the upper part of branches and stems. The root part is a tuber part that looks like a bulb and is pulsating with 1 ~ 3cm in length. Root area is reddish and milky. In other names, it is called Gamja, Jeokro, Gamroah, Jijam, Tochungcho, Jigocho, Jiyu, Earthworm, Botapchae, and Wahchae. Efficacy is known to be effective for fever, seawater, pneumonia, poisoning, blood loss, bleeding, boil, inflammation, analgesic, pneumonia, appendicitis, sore throat, mild fever, swelling. It is also known to be effective in preventing senile dementia and improving memory.
노루궁뎅이 버섯(Hericium erinaceum)은 산호버섯과에 속하는 버섯으로 가을철 활엽수의 고목이나 생목에서 발생하며, 중국에서는 원숭이 머리버섯 및 곰머리 버섯으로 알려져 있으며, 일본에서는 야마부시타케(Yamabushitake), 우리 나라에서는 노루궁뎅이의 털모양과 비슷하다고 하여 노루궁뎅이 버섯으로 알려져 있다. 이러한 노루궁뎅이 버섯에는 탄수화물, 단백질, 아미노산, 효소, 무기염류 및 비타민 등이 풍부하고, 항암 및 면역기능을 증대시키는 효능이 있다고 알려져 있으며, 최근에는 항암효과를 가진 성분을 비롯하여 다양한 생리활성물질을 함유하고 있는 것으로 보고된 바 있다.Roe Deer Mushroom ( Hericium) erinaceum ) is a fungi belonging to the Coral Mushroom family, which occurs in the hardwoods and trees of autumn hardwoods in autumn, and is known as monkey head mushrooms and bear head mushrooms in China, Yamabushitake in Japan, and the form of snail in Korea. It is known to be similar to roe deer mushroom. These mushrooms are rich in carbohydrates, proteins, amino acids, enzymes, inorganic salts, and vitamins, and are known to be effective in increasing anticancer and immune functions. Recently, they contain various biologically active substances, including ingredients with anticancer effects. It has been reported.
한편, 한국공개특허 제2016-0024525호는 초석잠 추출물을 유효성분으로 포함하는 화장료 조성물을 개시하고 있으며, 한국공개특허 제2004-0090114호는 노루궁뎅이버섯 추출물을 함유하는 피부 외용제 조성물을 개시하고 있다. 하지만, 본 발명의 노루궁뎅이버섯 균사체를 이용한 백복령 발효 추출물, 율무 발효 추출물 및 초석잠 발효 추출물의 혼합물을 유효성분으로 함유하는 피부 미백 및 주름 개선용 조성물에 대해 아직까지 개시된 바가 없다.On the other hand, Korean Patent Publication No. 2016-0024525 discloses a cosmetic composition comprising a choseok nap extract as an active ingredient, Korean Patent Publication No. 2004-0090114 discloses an external composition for skin containing a extract of snail mushroom extract. . However, the composition for skin whitening and wrinkle improvement containing the mixture of Baekbokyeong fermentation extract, Yulmu fermentation extract, and Choseok nap fermentation extract using the Roe mushroom fungus mycelium of the present invention as an active ingredient has not yet been disclosed.
본 발명은 상기와 같은 요구에 의해 도출된 것으로서, 본 발명에서는 노루궁뎅이버섯 균사체를 이용하여 백복령 발효 추출물, 율무 발효 추출물 및 초석잠 발효 추출물의 혼합물을 제조하였으며, 이를 대상으로 멜라닌생성 저해활성, 엘라스타아제 활성 저해 및 콜라게나아제 활성 저해 효과를 확인한 결과, 특정 혼합 비율로 제조한 백복령 발효 추출물, 율무 발효 추출물 및 초석잠 발효 추출물의 혼합물이 백복령, 율무 및 초석잠 각각의 발효 단독 추출물보다 피부 미백 및 주름 개선 효과가 현저하다는 것을 확인함으로써, 본 발명을 완성하였다.The present invention was derived by the above requirements, in the present invention was prepared a mixture of Baekbokryeong fermented extract, Yulmu fermented extract and Choseok fermented extract using the Roe locust fungus mycelium, the melanogenesis inhibitory activity, Ella As a result of confirming the inhibitory effect of statin activity and collagenase activity, the mixture of Baekbokryeong fermentation extract, Yulmu fermentation extract and Choseok nap fermentation extract prepared at specific mixing ratios whitened the skin than the fermentation extract of Baekbokyeong, Yulmu and Choseok nap respectively. And this invention was completed by confirming that a wrinkle improvement effect is remarkable.
상기 과제를 해결하기 위하여, 본 발명은 백복령 발효 추출물, 율무 발효 추출물 및 초석잠 발효 추출물의 혼합물을 유효성분으로 함유하는 피부 미백 및 주름 개선용 화장료 조성물을 제공한다.In order to solve the above problems, the present invention provides a cosmetic composition for improving skin whitening and wrinkles containing a mixture of Baekbokyeong fermentation extract, Yulmu fermentation extract and choseok nap fermentation extract as an active ingredient.
또한, 본 발명은 백복령 발효 추출물, 율무 발효 추출물 및 초석잠 발효 추출물의 혼합물을 유효성분으로 함유하는 피부 미백 및 주름 개선용 피부 외용제를 제공한다.In addition, the present invention provides a skin external preparation for skin whitening and wrinkle improvement containing a mixture of Baekbokyeong fermentation extract, Yulmu fermentation extract and Choseok nap fermentation extract as an active ingredient.
또한, 본 발명은 백복령 발효 추출물, 율무 발효 추출물 및 초석잠 발효 추출물의 혼합물을 유효성분으로 함유하는 피부 미백 및 주름 개선용 건강기능식품 조성물을 제공한다.In addition, the present invention provides a health functional food composition for improving skin whitening and wrinkles containing a mixture of Baekbokyeong fermentation extract, Yulmu fermentation extract and Choseok nap fermentation extract as an active ingredient.
본 발명의 특정 혼합 비율로 제조한 백복령 발효 추출물, 율무 발효 추출물 및 초석잠 발효 추출물의 혼합물이 백복령, 율무 및 초석잠 각각의 발효 단독 추출물보다 피부 미백 및 주름 개선 효과가 더 우수하므로, 피부 미백 또는 주름 개선을 위한 화장료, 건강기능식품 등에 더욱 유용하게 이용될 수 있다.Since the mixture of Baekbokryeong fermentation extract, Yulmu fermentation extract and Choseok sleep fermentation extract prepared at a specific mixing ratio of the present invention has better skin whitening and wrinkle improvement effect than the respective extracts of Baekbokyeong, Yulmu and Choseok sleep, fermentation alone, skin whitening or Cosmetics for wrinkle improvement, health functional foods can be used more usefully.
도 1은 본 발명의 일 구현 예에 따른 노루궁뎅이버섯 균사체를 이용하여 제조한 백복령 발효 추출물, 율무 발효 추출물 및 초석잠 발효 추출물의 혼합물을 B16F10 세포에 처리하였을 때, 세포생존율을 통해 세포독성을 확인한 결과이다.
도 2는 본 발명의 일 구현 예에 따른 노루궁뎅이버섯 균사체를 이용하여 제조한 백복령, 율무 및 초석잠 각각의 발효 단독 추출물과 이를 다양한 혼합 비율에 따라 제조한 혼합물의 멜라닌생성 저해활성을 비교한 결과이다.
도 3은 본 발명의 일 구현 예에 따른 노루궁뎅이버섯 균사체를 이용하여 제조한 백복령, 율무 및 초석잠 각각의 발효 단독 추출물과 이를 다양한 혼합 비율에 따라 제조한 혼합물의 엘라스타아제 활성 저해효과를 비교한 결과이다.
도 4는 본 발명의 일 구현 예에 따른 노루궁뎅이버섯 균사체를 이용하여 제조한 백복령, 율무 및 초석잠 각각의 발효 단독 추출물과 이를 다양한 혼합 비율에 따라 제조한 혼합물의 콜라게나아제 활성 저해효과를 비교한 결과이다.Figure 1 shows the cytotoxicity through cell viability when treated with B16F10 cells of the mixture of Baekbokryeong fermentation extract, Yulmu fermentation extract and Choseok nap fermentation extract prepared using the Roerung beetle mycelia according to one embodiment of the present invention The result is.
Figure 2 is a result of comparing the melanogenesis inhibitory activity of the fermentation extract of each of Baekbokryeong, Yulmu and Choseok nap prepared using the Roeung beetle mycelium mycelium according to an embodiment of the present invention and the mixture prepared according to various mixing ratios to be.
Figure 3 compares the effect of inhibiting the elastase activity of each of the fermentation extract of each of Baekbokryeong, Yulmu and Choseok nap prepared using the locust fungus Mycelium mycelium according to one embodiment of the present invention and the mixture prepared according to various mixing ratios. One result.
Figure 4 compares the inhibitory effect of collagenase activity of the fermentation extracts of each of Baekbokryeong, Yulmu and Choseok nap prepared by using the Roe mung mushroom mycelium according to an embodiment of the present invention and the mixture prepared according to various mixing ratios. One result.
본 발명의 목적을 달성하기 위하여, 본 발명은 백복령 발효 추출물, 율무 발효 추출물 및 초석잠 발효 추출물의 혼합물을 유효성분으로 함유하는 피부 미백 및 주름 개선용 화장료 조성물을 제공한다.In order to achieve the object of the present invention, the present invention provides a cosmetic composition for improving skin whitening and wrinkles containing a mixture of Baekbokyeong fermentation extract, Yulmu fermentation extract and Choseok nap fermentation extract as an active ingredient.
본 발명의 일 구현 예에 따른 화장료 조성물에서, 상기 발효는 노루궁뎅이버섯 균사체를 이용하여 발효시킨 것 수 있으나, 이에 제한되지 않는다.In the cosmetic composition according to an embodiment of the present invention, the fermentation may be fermented using a scab mushroom mycelium, but is not limited thereto.
또한, 상기 혼합물은 총 100 중량부에 대하여 15~25 중량부의 백복령 발효 추출물, 25~35 중량부의 율무 발효 추출물 및 45~55 중량부의 초석잠 발효 추출물을 포함하는 것일 수 있으며, 바람직하게는 20 중량부의 백복령 발효 추출물, 30 중량부의 율무 발효 추출물 및 50 중량부의 초석잠 발효 추출물을 포함하는 것일 수 있으나, 이에 제한되지 않는다.In addition, the mixture may be one containing 15 to 25 parts by weight of Baekbokyeong fermentation extract, 25 to 35 parts by weight of Yulmu fermentation extract and 45 to 55 parts by weight of Choseok fermented extract, preferably 20 parts by weight. Bokbokyeong fermentation extract, 30 parts by weight of yulmu fermentation extract and may include 50 parts by weight of salt-free fermentation extract, but is not limited thereto.
또한, 상기 백복령 발효 추출물, 율무 발효 추출물 및 초석잠 발효 추출물은 백복령, 율무 및 초석잠 각각의 발효물을 여과하고 남은 잔여물을 동결건조한 후, 열수 추출하여 제조된 것일 수 있으나, 이에 제한되지 않는다.In addition, the Baekbokryeong fermentation extract, Yulmu fermentation extract and choseok sleep fermentation extract may be prepared by filtering the fermentation of each of the Baekbokyeong, Yulmu and Choseok sleep and freeze-dried the remaining residue, followed by hot water extraction, but is not limited thereto. .
또한, 상기 백복령 발효 추출물, 율무 발효 추출물 및 초석잠 발효 추출물의 혼합물은In addition, the mixture of the Baekbokryeong fermented extract, Yulmu fermented extract and Choseok fermented extract are
1) 배지 100 중량부에 대하여 7~12 중량부의 백복령, 17~22 중량부의 율무 및 12~17 중량부의 초석잠을 각각 첨가하여 110~130℃에서 10~20분 동안 멸균하는 단계;1) sterilizing at 110-130 ° C. for 10-20 minutes by adding 7-12 parts by weight of baekbokyeong, 17-22 parts by weight of yulmu and 12-17 parts by weight of zeolite to 100 parts by weight of medium, respectively;
2) 상기 단계 1)에서 멸균한 각 재료가 첨가된 배지에 노루궁뎅이버섯 균사체 배양액을 각각 접종하여 24~26℃에서 7~12일 동안 발효하는 단계;2) inoculating each of the Roe mushroom fungus mycelium culture medium to each of the ingredients sterilized in step 1) and fermenting at 24 to 26 ℃ for 7 to 12 days;
3) 상기 단계 2)에서 획득한 각각의 발효물을 여과하고, 남은 잔여물을 동결건조하는 단계;3) filtering each fermentation product obtained in step 2) and lyophilizing the remaining residue;
4) 상기 단계 3)의 동결건조한 각각의 발효물을 75~85℃에서 열수 추출하여 백복령 발효 추출물, 율무 발효 추출물 및 초석잠 발효 추출물을 획득하는 단계; 및 4) obtaining each of the lyophilized fermented product of step 3) by hot water extraction at 75-85 ° C. to obtain Baekbokryeong fermentation extract, Yulmu fermentation extract and Choseok fermented fermentation extract; And
5) 상기 단계 4)에서 획득한 백복령 발효 추출물, 율무 발효 추출물 및 초석잠 발효 추출물을, 총 100 중량부에 대하여 15~25 중량부의 백복령 발효 추출물, 25~35 중량부의 율무 발효 추출물 및 45~55 중량부의 초석잠 발효 추출물을 혼합하여 혼합물을 제조하는 단계;를 포함하여 제조하는 것일 수 있으며,5) 15 to 25 parts by weight of Baekbokryeong fermentation extract, jujube fermentation extract and choseokmu fermentation extract obtained in step 4), 15 to 25 parts by weight of Baekbokyeong fermentation extract, 25 to 35 parts by weight of Yulmu fermentation extract and 45 to 55 To prepare a mixture by mixing parts by weight of salt-free fermentation extract; may be to include,
바람직하게는Preferably
1) 배지 100 중량부에 대하여 10 중량부의 백복령, 20 중량부의 율무 및 15 중량부의 초석잠을 각각 첨가하여 121℃에서 15분 동안 멸균하는 단계;1) sterilizing at 121 ° C. for 15 minutes by adding 10 parts by weight of Baek-bok-yeong, 20 parts by weight of yulmu and 15 parts by weight of zeolite per 100 parts by weight of medium;
2) 상기 단계 1)에서 멸균한 각 재료가 첨가된 배지에 노루궁뎅이버섯 균사체 배양액을 각각 접종하여 25℃에서 10일 동안 발효하는 단계;2) inoculating each of the Roe mushroom fungus mycelium culture medium in each medium sterilized in step 1) and fermenting at 25 ° C. for 10 days;
3) 상기 단계 2)에서 획득한 각각의 발효물을 여과하고, 남은 잔여물을 동결건조하는 단계;3) filtering each fermentation product obtained in step 2) and lyophilizing the remaining residue;
4) 상기 단계 3)의 동결건조한 각각의 발효물을 80℃에서 열수 추출하여 백복령 발효 추출물, 율무 발효 추출물 및 초석잠 발효 추출물을 획득하는 단계; 및 4) extracting each of the lyophilized fermented product of step 3) by hot water extraction at 80 ° C. to obtain Baekbokryeong fermentation extract, Yulmu fermentation extract and Choseok fermented fermentation extract; And
5) 상기 단계 4)에서 획득한 백복령 발효 추출물, 율무 발효 추출물 및 초석잠 발효 추출물을, 총 100 중량부에 대하여 20 중량부의 백복령 발효 추출물, 30 중량부의 율무 발효 추출물 및 50 중량부의 초석잠 발효 추출물을 혼합하여 혼합물을 제조하는 단계;를 포함하여 제조하는 것일 수 있으나, 이에 제한되지 않는다.5) 20 parts by weight of Baekbok-Ryeong fermentation extracts, 50 parts by weight of Yulmu fermentation extracts and 50 parts by weight of Choseok fermentation extracts, based on 100 parts by weight, To prepare a mixture by mixing the; may be prepared to include, but is not limited thereto.
또한, 상기 단계 1)에서 배지는 버섯 균사 배양용 배지이며, PDB(potato dextrose broth) 배지를 일반적으로 사용할 수 있으나, 이에 제한되지 않는다.In addition, in step 1), the medium is a culture medium for mushroom hyphae, and PDB (potato dextrose broth) medium may be generally used, but is not limited thereto.
본 발명의 일 구현 예에 따른 화장료 조성물에 있어서, 상기 피부 미백 및 주름 개선용 화장료 조성물은 피부외용 연고, 크림, 유연화장수, 영양화장수, 팩, 에센스, 헤어토닉, 샴푸, 린스, 헤어 컨디셔너, 헤어 트리트먼트, 젤, 스킨로션, 스킨소프너, 스킨토너, 아스트린젠트, 로션, 밀크로션, 모이스처 로션, 영양로션, 마사지 크림, 영양크림, 모이스처 크림, 핸드 크림, 파운데이션, 영양에센스, 선스크린, 비누, 클렌징폼, 클렌징로션, 클렌징크림, 바디 로션 및 바디 클렌저로 이루어지는 군으로부터 선택된 어느 하나의 제형으로 제조되는 것일 수 있으나, 이에 제한되지 않는다. 이들 각 제형으로 이루어진 화장료 조성물은 그 제형의 제제화에 필요하고 적절한 각종의 기제와 첨가물을 함유할 수 있으며, 이들 성분의 종류와 양은 당업자에 의해 용이하게 선정될 수 있다.In the cosmetic composition according to an embodiment of the present invention, the cosmetic composition for improving skin whitening and wrinkles is an external skin ointment, cream, supple cosmetics, nourishing cosmetics, pack, essence, hair tonic, shampoo, conditioner, hair conditioner, hair Treatment, Gel, Skin Lotion, Skin Softener, Skin Toner, Astringent, Lotion, Milk Lotion, Moisture Lotion, Nutrition Lotion, Massage Cream, Nutrition Cream, Moisture Cream, Hand Cream, Foundation, Nutrition Essence, Sunscreen, Soap, Cleansing Foam, cleansing lotion, cleansing cream, body lotion and body cleanser may be prepared in any one formulation selected from the group consisting of, but is not limited thereto. The cosmetic composition consisting of each of these formulations may contain various bases and additives necessary for the formulation of the formulation and are suitable, and the type and amount of these components can be easily selected by those skilled in the art.
본 발명의 화장료 조성물은 유효성분 이외에 추가로 동일 또는 유사한 기능을 나타내는 피부 미백 활성 성분을 1종 이상 함유할 수 있다. 피부 미백 활성 성분으로는 코지산 및 이의 유도체, 알부틴, 아스코르브산 및 이의 유도체, 하이드로퀴논 및 이의 유도체, 레조르시놀, 사이클로알카논, 메틸렌디옥시페닐 알칸올, 2,7-디니트로인다졸 또는 덩굴귤 추출물, 쌀 추출물, 감초 추출물과 같은 식물 추출물 등이 있으나, 이에 제한되는 것은 아니다.The cosmetic composition of the present invention may further contain one or more skin whitening active ingredients exhibiting the same or similar functions in addition to the active ingredient. Skin whitening active ingredients include kojic acid and derivatives thereof, arbutin, ascorbic acid and derivatives thereof, hydroquinone and derivatives thereof, resorcinol, cycloalkanone, methylenedioxyphenyl alkanol, 2,7-dinitroindazole or Plant extracts such as vine tangerine extract, rice extract, licorice extract, and the like, but is not limited thereto.
본 발명의 화장료 조성물의 제형이 페이스트, 크림 또는 겔인 경우에는 담체 성분으로서 동물섬유, 식물섬유, 왁스, 파라핀, 전분, 트라가칸트, 셀룰로오스 유도체, 폴리에틸렌 글리콜, 실리콘, 벤토나이트, 실리카, 탈크 또는 산화아연 등이 이용될 수 있다.When the formulation of the cosmetic composition of the present invention is a paste, cream or gel, the carrier component is animal fiber, vegetable fiber, wax, paraffin, starch, tragacanth, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc or zinc oxide. And the like can be used.
본 발명의 화장료 조성물의 제형이 파우더 또는 스프레이인 경우에는 담체 성분으로서 락토스, 탈크, 실리카, 알루미늄 히드록시드, 칼슘 실리케이트 또는 폴리아미드 파우더가 이용될 수 있고, 특히 스프레이인 경우에는 추가적으로 클로로플루오로히드로카본, 프로판-부탄 또는 디메틸 에테르와 같은 추진체를 포함할 수 있다.When the formulation of the cosmetic composition of the present invention is a powder or a spray, lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder may be used as the carrier component, and in particular, in the case of a spray, additionally chlorofluorohydro Propellants such as carbon, propane-butane or dimethyl ether.
본 발명의 화장료 조성물의 제형이 용액 또는 유탁액의 경우에는 담체 성분으로서 용매, 용매화제 또는 유탁화제가 이용되고, 예컨대 물, 에탄올, 이소프로판올, 에틸 카보네이트, 에틸 아세테이트, 벤질 알코올, 벤질 벤조에이트, 프로필렌글리콜, 1,3-부틸글리콜 오일, 글리세롤 지방족 에스테르, 폴리에틸렌 글리콜 또는 소르비탄의 지방산 에스테르가 있다.When the formulation of the cosmetic composition of the present invention is a solution or emulsion, a solvent, solvating agent or emulsifying agent is used as a carrier component, such as water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene. Fatty acid esters of glycol, 1,3-butylglycol oil, glycerol aliphatic ester, polyethylene glycol or sorbitan.
본 발명의 화장료 조성물의 제형이 현탁액인 경우에는 담체 성분으로서 물, 에탄올 또는 프로필렌 글리콜과 같은 액상 희석제, 에톡실화 이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르 및 폴리옥시에틸렌 소르비탄 에스테르와 같은 현탁제, 미소결정성 셀룰로오스, 알루미늄 메타히드록시드, 벤토나이트, 아가 또는 트라칸트 등이 이용될 수 있다.When the formulation of the cosmetic composition of the present invention is a suspension, as a carrier component, water, a liquid diluent such as ethanol or propylene glycol, a suspending agent such as ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester, Microcrystalline cellulose, aluminum metahydroxy, bentonite, agar or tracant and the like can be used.
본 발명의 화장료 조성물의 제형이 계면-활성제 함유 클렌징인 경우에는 담체 성분으로서 지방족 알코올 설페이트, 지방족 알코올 에테르설페이트, 설포숙신산 모노에스테르, 아세티오네이트, 이미다졸리늄 유도체, 메틸타우레이트, 사르코시네이트, 지방산 아미드 에테르 설페이트, 알킬아미도베타인, 지방족 알코올, 지방산 글리세리드, 지방산 디에탄올아미드, 식물성 유, 리놀린 유도체 또는 에톡실화 글리세롤 지방산 에스테르 등이 이용될 수 있다.When the formulation of the cosmetic composition of the present invention is a surfactant-containing cleansing agent, the carrier component is an aliphatic alcohol sulfate, an aliphatic alcohol ether sulfate, a sulfosuccinic acid monoester, acethionate, an imidazolinium derivative, a methyltaurate, or a sarcosinate. Fatty acid amide ether sulfates, alkylamidobetaines, aliphatic alcohols, fatty acid glycerides, fatty acid diethanolamides, vegetable oils, linolin derivatives or ethoxylated glycerol fatty acid esters and the like can be used.
본 발명의 화장료 조성물은 형광물질, 살진균제, 굴수성 유발물질, 보습제, 방향제, 방향제 담체, 단백질, 용해화제, 당 유도체, 일광차단제, 비타민, 식물 추출물 등을 포함하는 부형제를 추가로 함유할 수 있다.The cosmetic composition of the present invention may further contain an excipient including a fluorescent substance, a fungicide, a caustic agent, a moisturizer, a fragrance, a fragrance carrier, a protein, a solubilizer, a sugar derivative, a sunscreen agent, a vitamin, a plant extract, and the like. .
또한, 본 발명은 백복령 발효 추출물, 율무 발효 추출물 및 초석잠 발효 추출물의 혼합물을 유효성분으로 함유하는 피부 미백 및 주름 개선용 피부 외용제를 제공한다.In addition, the present invention provides a skin external preparation for skin whitening and wrinkle improvement containing a mixture of Baekbokyeong fermentation extract, Yulmu fermentation extract and Choseok nap fermentation extract as an active ingredient.
본 발명의 피부 외용제는 당업계의 공지기술을 참조하여 통상적으로 제조되는 어떠한 제형으로도 제조될 수 있다. 예를 들어, 용액, 현탁액, 유탁액, 유연 화장수, 영양 화장수, 페이스트, 겔, 크림, 로션, 에센스, 에멀전, 팩, 세안제, 겔, 파우더, 비누, 계면활성제-함유 클린싱, 오일, 분말 파운데이션, 유탁액 파운데이션, 왁스 파운데이션 및 스프레이 등으로 제형화될 수 있으나, 이에 한정되는 것은 아니다. 보다 상세하게는, 유연 화장수, 영양 화장수, 영양크림, 마사지크림, 에센스, 아이크림, 클렌징크림, 클렌징폼, 클렌징워터, 마스크팩, 스프레이 또는 파우더의 제형으로 제조될 수 있다.The external preparation for skin of the present invention may be prepared in any formulation conventionally prepared with reference to the known art. For example, solutions, suspensions, emulsions, softening lotions, nourishing lotions, pastes, gels, creams, lotions, essences, emulsions, packs, face washes, gels, powders, soaps, surfactant-containing cleansing, oils, powder foundations, It may be formulated as an emulsion foundation, wax foundation, spray, and the like, but is not limited thereto. More specifically, it may be prepared in the form of a flexible lotion, nutrition lotion, nutrition cream, massage cream, essence, eye cream, cleansing cream, cleansing foam, cleansing water, mask pack, spray or powder.
상기 백복령 발효 추출물, 율무 발효 추출물 및 초석잠 발효 추출물의 혼합물을 피부 외용제로 이용하기 위하여 추가로 지방 물질, 유기 용매, 용해제, 농축제 및 겔화제, 연화제, 항산화제, 현탁화제, 안정화제, 발포제(foaming agent), 방향제, 계면활성제, 물, 이온형 또는 비이온형 유화제, 충전제, 금속이온봉쇄제 및 킬레이트화제, 보존제, 비타민, 차단제, 습윤화제, 필수 오일, 염료, 안료, 친수성 또는 친유성 활성제, 지질 소낭 또는 피부용 외용제에 통상적으로 사용되는 임의의 다른 성분과 같은 피부 과학 분야에서 통상적으로 사용되는 보조제를 함유할 수 있다. 또한, 상기 성분들은 피부 과학 분야에서 일반적으로 사용되는 양으로 도입될 수 있다.Fatty substances, organic solvents, solubilizers, thickeners and gelling agents, emollients, antioxidants, suspending agents, stabilizers, foaming agents in order to use the mixture of the Baekbokryeong fermentation extract, Yulmu fermentation extract, and Choseok nap fermentation extract as external preparations for skin (foaming agents), fragrances, surfactants, water, ionic or nonionic emulsifiers, fillers, metal ion sequestrants and chelating agents, preservatives, vitamins, blockers, wetting agents, essential oils, dyes, pigments, hydrophilic or lipophilic It may contain adjuvants commonly used in the field of dermatology, such as active agents, lipid vesicles or any other ingredients commonly used in external preparations for skin. In addition, the ingredients may be introduced in amounts generally used in the field of dermatology.
또한, 본 발명은 백복령 발효 추출물, 율무 발효 추출물 및 초석잠 발효 추출물의 혼합물을 유효성분으로 함유하는 피부 미백 및 주름 개선용 건강기능식품 조성물을 제공한다.In addition, the present invention provides a health functional food composition for improving skin whitening and wrinkles containing a mixture of Baekbokyeong fermentation extract, Yulmu fermentation extract and Choseok nap fermentation extract as an active ingredient.
상기 조성물은 분말, 과립, 환, 정제, 캡슐, 캔디, 시럽 및 음료 중에서 선택된 어느 하나의 제형으로 제조되는 것일 수 있으나, 이에 제한되지 않는다.The composition may be prepared in any one of powder, granules, pills, tablets, capsules, candy, syrups and beverages, but is not limited thereto.
본 발명의 건강기능식품 조성물을 식품첨가물로 사용하는 경우, 상기 건강기능식품 조성물을 그대로 첨가하거나 다른 식품 또는 식품성분과 함께 사용될 수 있고, 통상적인 방법에 따라 적절하게 사용될 수 있다. 유효성분은 그의 사용 목적에 따라 적절하게 사용될 수 있다. 일반적으로, 식품 또는 음료의 제조시 본 발명의 건강기능식품 조성물은 원료에 대하여 15 중량부 이하, 바람직하게는 10 중량부 이하의 양으로 첨가된다. 그러나 건강을 목적으로 하는 장기간의 섭취의 경우에는 상기 양은 상기 범위 이하일 수 있으며, 안전성 면에서 아무런 문제가 없기 때문에 유효성분은 상기 범위 이상의 양으로 사용될 수 있다.When the health functional food composition of the present invention is used as a food additive, the health functional food composition may be added as it is or used with other foods or food ingredients, and may be appropriately used according to a conventional method. The active ingredient may be appropriately used depending on the purpose of use thereof. In general, in the preparation of food or beverages, the nutraceutical composition of the present invention is added in an amount of 15 parts by weight or less, preferably 10 parts by weight or less with respect to the raw material. However, in the case of long-term intake for health purposes, the amount may be below the above range, and since there is no problem in terms of safety, the active ingredient may be used in an amount above the above range.
상기 건강기능식품의 종류에 특별한 제한은 없다. 상기 건강기능식품 조성물을 첨가할 수 있는 식품의 예로는 육류, 소시지, 빵, 초콜릿, 캔디류, 스낵류, 과자류, 피자, 라면, 기타 면류, 껌류, 아이스크림류를 포함한 낙농제품, 각종 스프, 음료수, 차 드링크제, 알콜 음료 및 비타민 복합제 등이 있으며, 통상적인 의미에서의 건강식품을 모두 포함한다.There is no particular limitation on the type of dietary supplement. Examples of foods to which the health functional food composition may be added include meat, sausage, bread, chocolate, candy, snacks, confectionery, pizza, ramen, other noodles, gums, dairy products, including ice cream, various soups, drinks, tea Drinks, alcoholic beverages, vitamin complexes, and the like, and include all health foods in the conventional sense.
또한, 본 발명의 건강기능식품 조성물은 식품, 특히 기능성 식품으로 제조될 수 있다. 본 발명의 기능성 식품은 통상적으로 첨가되는 성분을 포함할 수 있다. 예를 들어, 단백질, 탄수화물, 지방, 영양소 및 조미제를 포함한다. 예컨대, 드링크제로 제조되는 경우에는 유효성분 이외에 천연 탄수화물 또는 향미제를 추가 성분으로서 포함시킬 수 있다. 상기 천연 탄수화물은 모노사카라이드(예컨대, 글루코오스, 프럭토오스 등), 디사카라이드(예컨대, 말토스, 수크로오스 등), 올리고당, 폴리사카라이드(예컨대, 덱스트린, 시클로덱스트린 등) 또는 당알코올(예컨대, 자일리톨, 소르비톨, 에리쓰리톨 등)인 것이 바람직하다. 상기 향미제는 천연 향미제(예컨대, 타우마틴, 스테비아 추출물 등)와 합성 향미제(예컨대, 사카린, 아스파르탐 등)를 이용할 수 있다.In addition, the nutraceutical composition of the present invention may be prepared as a food, in particular a functional food. The functional food of the present invention may include ingredients that are commonly added. Examples include proteins, carbohydrates, fats, nutrients and seasonings. For example, when prepared with a drink, natural carbohydrates or flavors may be included as additional ingredients in addition to the active ingredient. The natural carbohydrates can be monosaccharides (e.g. glucose, fructose, etc.), disaccharides (e.g. maltose, sucrose, etc.), oligosaccharides, polysaccharides (e.g. dextrins, cyclodextrins, etc.) or sugar alcohols (e.g. , Xylitol, sorbitol, erythritol and the like). The flavourant may be a natural flavourant (eg, taumartin, stevia extract, etc.) and a synthetic flavourant (eg, saccharin, aspartame, etc.).
상기 건강기능식품 조성물 이외에 여러 가지 영양제, 비타민, 전해질, 풍미제, 착색제, 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알콜, 탄산음료에 사용되는 탄산화제 등을 더 함유할 수 있다. 이러한 상기 첨가되는 성분의 비율은 크게 중요하진 않지만 본 발명의 건강기능식품 조성물 100 중량부에 대하여, 0.01 내지 0.1 중량부의 범위에서 선택되는 것이 일반적이다.Various nutritional supplements, vitamins, electrolytes, flavors, coloring agents, pectic acid and salts thereof, alginic acid and salts thereof, organic acids, protective colloid thickeners, pH regulators, stabilizers, preservatives, glycerin, alcohols, carbonic acid The carbonation agent etc. which are used for a drink can be contained further. Although the ratio of the above-mentioned ingredients is not critical, it is generally selected from 0.01 to 0.1 parts by weight based on 100 parts by weight of the health functional food composition of the present invention.
이하, 실시예를 이용하여 본 발명을 더욱 상세하게 설명하고자 한다. 이들 실시예는 오로지 본 발명을 보다 구체적으로 설명하기 위한 것으로 본 발명의 범위가 이들에 의해 제한되지 않는다는 것은 당해 기술분야에서 통상의 지식을 가진 자에게 있어 자명한 것이다. Hereinafter, the present invention will be described in more detail with reference to Examples. These examples are only for explaining the present invention in more detail, it is obvious to those skilled in the art that the scope of the present invention is not limited by them.
제조예Production Example 1. One. 백복령Baikyeongryeong , 율무 및 , Law and 초석잠Cornerstone 발효 단독 추출물과 이를 혼합한 혼합물의 제조 Preparation of Fermented Sole Extract and Mixture Mixed with It
백복령, 율무 및 초석잠 발효물 제조에 사용할 노루궁뎅이버섯 균사체는 PDA 배지에 배양한 노루궁뎅이버섯 균사체가 5-6 cm로 자라면 가장자리의 균사체를 코르크 보러(Cork borer)를 이용하여 떼어낸 다음, 균사편 5개를 접종원으로 하여 PDB 배지 100㎖에 접종한 후 진탕배양기(25℃, 150 rpm)에서 7일간 배양하였다. The worm fungus mycelium used for the production of Baekbokryeong, yulmu and salt-free fermentation products, when the worm mushroom mycelium grown in PDA medium grows to 5-6 cm, the mycelium at the edges is removed by cork borer. Five mycelia were inoculated into 100 mL of PDB medium using the inoculum and incubated for 7 days in a shaker (25 ° C, 150 rpm).
PDB 배지 1ℓ에 백복령 100g, 율무 200g 및 초석잠 150g을 각각 첨가한 후 오토클래이브를 이용하여 121℃에서 15분 동안 멸균하였다. 멸균한 배지에 상기 방법으로 배양한 노루궁뎅이버섯 균사체를 접종하여 진탕배양기(25℃ 및 150 rpm)에서 10일간 배양한 후 여과지를 사용하여 여과하고 남은 잔사를 동결건조기를 이용하여 동결건조하였다. 동결건조한 발효물을 에탄올, 열수 및 정제수로 각각 추출한 후 여과하여, 노루궁뎅이버섯 균사체를 이용한 백복령, 율무 및 초석잠 각각의 발효 추출물을 각각 제조하였다. 100 g of Baekbokryeong, 200 g of yeast radish and 150 g of Choseokjam were added to 1 L of PDB medium, and then sterilized at 121 ° C. for 15 minutes using an autoclave. Inoculated with the mycelia of the Roe mushroom fungus mycelium cultured in the above method in a sterile medium for 10 days in a shake culture (25 ℃ and 150 rpm), filtered using a filter paper and the remaining residue was freeze-dried using a freeze dryer. The lyophilized fermented product was extracted with ethanol, hot water, and purified water, and then filtered to prepare fermented extracts of Baekbokryeong, Yulmu, and Choseokjam, respectively.
또한, 상기 제조된 백복령, 율무 및 초석잠 각각의 발효 단독 추출물을 하기 표 1에 개시한 바와 같이 5종의 혼합 비율로 혼합하여 혼합물들을 제조하였다.In addition, the fermented extracts of each of the prepared Baekbokryeong, Yulmu and Choseokjam were mixed at five mixing ratios as described in Table 1 to prepare mixtures.
발효 백복령Roe deer beetle mycelia
Fermented Baekbokyeong
발효 율무Roe deer beetle mycelia
Fermentation rate
발효 초석잠Roe deer beetle mycelia
실시예Example 1. One. 백복령Baikyeongryeong , 율무 및 , Law and 초석잠Cornerstone 발효 추출물의 제조 및 이의 최적조건 탐색 Preparation of Fermented Extracts and Their Optimum Conditions
백복령, 율무 및 초석잠의 첨가량에 따른 표고, 눈꽃동충하초, 치마버섯, 노루궁뎅이 및 상황버섯의 균사 생장을 측정하기 위하여, 각각의 버섯 균사체를 15일간 배양하여 균사 밀도를 측정하였다. 그 결과, 하기 표 2에 개시한 바와 같이 표고, 치마버섯 및 상황 균사의 경우, 율무, 초석잠 및 백복령 순으로 균사 밀도가 높게 나타났으며, 눈꽃동충하초 균사는 백복령을 첨가한 배지에서는 균사 생장이 이루어지지 않았다. 노루궁뎅이 균사는 율무, 백복령 및 초석잠 순으로 나타났으며, 5종의 버섯 균사 중 가장 높은 균사 밀도를 나타내었다. 백복령과 율무는 전반적으로 첨가량이 증가할수록 균사 밀도가 높게 나타났으나, 초석잠은 첨가량이 증가할수록 균사 밀도가 전반적으로 낮아지는 것을 확인하였다(표 2). In order to measure the mycelial growth of algae, snow Cordyceps sinensis, skirt mushroom, roe beet and S. mushrooms according to the amount of Baek Bok-Ryeong, Yul-Moo and Suk-Tap, each mushroom mycelium was incubated for 15 days and the mycelial density was measured. As a result, as shown in Table 2, in the case of shiitake, skirt mushroom and situation hyphae, mycelial densities were higher in order of Yulmu, Choseokjab, and Baekbokryeong. It was not done. Roe beetle mycelia were found in the order of Yulmu, Baekbokyeong, and Choseokpyeong, showing the highest mycelial density among the five mushroom mycelia. The overall mycelial density of Baekbokryeong and Yulmu increased as the amount added, but the mycelial density decreased as the amount added increased.
또한, 상기 균사밀도가 가장 우수하였던 노루궁뎅이버섯 균주의 균주배양 최적 온도를 조사하기 위하여, 배양온도를 달리하여 25일간 배양한 균사 밀도를 측정하였다. 그 결과, 22∼28℃의 조건에서 균사 밀도가 높게 나타났으며, 그 중 24~26℃의 조건에서 각각 287.8mg 및 275.4mg으로 나타나 노루궁뎅이버섯의 최적 균사배양 온도는 24∼26℃가 적합한 것을 확인하였다(표 3).In addition, in order to investigate the optimum strain culture temperature of the Roe mushroom species, which was the most excellent mycelial density, the mycelial density of 25 days at different culture temperatures was measured. As a result, the mycelial density was high under the conditions of 22 ~ 28 ℃, and 287.8mg and 275.4mg, respectively, under the conditions of 24 ~ 26 ℃. It was confirmed (Table 3).
또한, 백복령, 율무 및 초석잠의 첨가량에 따른 노루궁뎅이버섯의 균사 생장을 확인하기 위하여, 균사 밀도를 측정하였다. 그 결과, 하기 표 4에 개시한 바와 같이 율무 첨가가 노루궁뎅이버섯의 균사 생장에 가장 우수한 효과를 나타내는 것을 확인하였다. 율무 200g을 첨가하였을 때 노루궁뎅이버섯 균사 밀도가 304.1g으로 가장 높게 나타났으며, 약용식물 종류별 첨가 최적 함량으로는 백복령 100g, 초석잠 150g으로 균사밀도는 각각 224.4 mg, 246.8mg으로 확인되었다.In addition, the mycelial density was measured in order to confirm the mycelial growth of the Roe beetle mushroom according to the addition amount of Baekbokyeong, Yulmu and Choseok nap. As a result, as shown in Table 4, it was confirmed that the addition of Yulmu showed the best effect on the mycelial growth of the scaber mushroom. When 200g of Yulmu was added, the density of mycelia was increased to 304.1g. The optimum content of medicinal plants was 100g of Baekbok-ryeong and 150g of Choseokseok, and the mycelial density of 224.4 mg and 246.8mg, respectively.
(g/L)Amount
(g / L)
동충하초Snow Flower
Cordyceps sinensis
(g/L)Medicinal Plant Content
(g / L)
실시예Example 2. 2. 백복령Baikyeongryeong , 율무 및 , Law and 초석잠Cornerstone 발효 추출물의 용매별 추출 수율 확인 Confirmation of Extraction Yield by Solvent of Fermented Extracts
상기 실시예 1을 통해 노루궁뎅이버섯 균사의 발효 최적 약용식물 첨가량은 백복령 100g/L, 율무 200g/L 및 초석잠 150g/L으로 확인되었다. 상기 발효 추출물들을 여과한 후 동결건조하여 최적 추출조건 탐색을 위하여 에탄올, 열수 및 정제수로 추출한 후 여과하여 고형분 함량을 계산하여 수율을 측정하였다. The fermentation optimum medicinal plant added amount of snail mushroom hyphae mycelium through Example 1 was confirmed as 100g / L Baekryongyeong, 200g / L yulmu and 150g / L Choseok nap. The fermented extracts were filtered and then lyophilized to extract ethanol, hot water and purified water to find the optimal extraction conditions, and filtered to calculate the solid content to calculate the yield.
그 결과, 하기 표 5에 개시한 바와 같이 노루궁뎅이버섯 균사를 이용하여 발효시킨 백복령, 율무 및 초석잠 모두 80℃ 조건의 열수 추출에서 6.7%, 7.4% 및 7.1%로 가장 높은 것을 확인하였다.As a result, as shown in Table 5 below, all of the Baekbokryeong, Yulmu, and Choseok nap fermented with the Roe beetle mycelium mycelium were found to be the highest as 6.7%, 7.4%, and 7.1% in hot water extraction under 80 ° C.
발효 초석잠Roe deer mushroom fungus mycelia
Fermentation Cornerstone
실시예Example 3. 3. 백복령Baikyeongryeong , 율무 및 , Law and 초석잠Cornerstone 발효 추출물의 혼합물 제조 및 이의 세포 생존율(cell viability) 확인 Preparation of Mixture of Fermented Extracts and Confirmation of Cell Viability thereof
B16F10 마우스 멜라노마(mouse melanoma) 세포를 배양하여 96-웰 플레이트에 각 웰당 1×105 세포수/㎖를 분주하고 배양하여 24시간 동안 안정화시킨 후, 노루궁뎅이버섯 균사체를 이용하여 제조한 백복령, 율무 및 초석잠 발효 추출물의 혼합물을 각각 10, 30, 50, 10 및 200㎍/㎖의 농도로 처리하여 24시간 반응 후 MTT(3-(4,5-디메틸디아졸-2-일)-2,5-데펜테르라졸리움 프로미드) 시약을 10㎕ 첨가하여 4시간 동안 포르마잔(formazan)을 형성시켰다. 반응이 끝나면 배지를 제거하고 디메틸 설폭시드(dimethyl sulfoxide; DMSO)로 포르마잔을 용해시켜 ELISA 리더를 이용하여 540nm에서 흡광도를 측정하고 그 결과를 아무것도 처리하지 않은 대조군 값에 대한 비율로 계산하였다. 그 결과, 도 1에 개시한 바와 같이 본 발명의 노루궁뎅이버섯 균사체를 이용하여 다양한 혼합 비율로 혼합하여 제조한 백복령, 율무 및 초석잠 발효 추출물의 혼합물들은 모든 처리농도에서 100%의 세포생존율을 보여 세포 독성이 없는 것을 확인하였다.After culturing B16F10 mouse melanoma cells and dispensing 1 × 10 5 cells / ml of each well in a 96-well plate and incubating them for 24 hours, Baekbokryeong prepared using the worm fungus mycelium, MTT (3- (4,5-dimethyldiazol-2-yl) -2 after 24 hours reaction was carried out by treating the mixture of Yulmu and Choseokjam fermentation extracts at concentrations of 10, 30, 50, 10 and 200 µg / ml, respectively. 10 μl of, 5-depenterazolium promid) reagent was added to form formazan for 4 hours. After the reaction was completed, the medium was removed, formazan was dissolved in dimethyl sulfoxide (DMSO), and the absorbance was measured at 540 nm using an ELISA reader, and the result was calculated as a ratio with respect to the untreated control value. As a result, as shown in FIG. 1, the mixtures of Baekbokryeong, Yulmu, and Choseok fermented extracts, which were prepared by mixing at various mixing ratios by using the Roe mung mushroom mycelium of the present invention, showed 100% cell viability at all treatment concentrations. It was confirmed that there was no cytotoxicity.
실시예Example 4. 4. 백복령Baikyeongryeong , 율무 및 , Law and 초석잠Cornerstone 발효 추출물의 혼합물 처리에 따른 멜라닌 생성 저해효과 확인 Confirmation of melanin production inhibitory effect of mixture of fermented extract
멜라닌 생성량 측정은 호세이 등의 방법(Hosei et al., 1985, Cancer Res., 45, 1474-1478)을 변형하여 사용하였다. B16/F10 멜라노 세포를 배양하여 24 웰 플레이트에 각 웰당 세포를 1×105 세포/웰에 본 발명의 백복령, 율무 및 초석잠 발효 추출물의 혼합물(표 1)을 처리한 후 48시간 배양하였다. 48시간 배양한 후 각 웰을 PBS로 세척한 후 0.2N NaOH 용액 400㎕를 첨가하고 60℃에서 1시간 동안 용해하였으며, ELISA 리더(Molecular Devices, USA)를 이용하여 405㎚에서 흡광도를 측정하였다. 그 결과, 도 2에 개시한 바와 같이 노루궁뎅이버섯 균사체를 이용하여 제조한 백복령, 율무 및 초석잠 각각의 발효 추출물과 이를 다양한 혼합 비율에 따라 제조한 A, B, C, D 및 E 혼합물(표 1)들의 멜라닌생성 저해효과를 비교하였을 때, 100 및 200㎎/㎖의 D 혼합물 처리시 단독 발효 추출물과 A, B, C 및 E 혼합물보다 멜라닌생성 저해효과가 현저하다는 것을 확인할 수 있었다.Melanin production was measured using a modification of Hosei et al. (Hosei et al., 1985, Cancer Res., 45, 1474-1478). B16 / F10 melanocytes were cultured and incubated for 24 hours after treatment with a mixture of Baekbokryeong, Yulmu and Choseok fermented extracts of the present invention (Table 1) in 1 × 10 5 cells / well in a 24 well plate. After 48 hours of incubation, each well was washed with PBS, 400 μl of 0.2N NaOH solution was added thereto, and dissolved at 60 ° C. for 1 hour. The absorbance was measured at 405 nm using an ELISA reader (Molecular Devices, USA). As a result, as shown in FIG. 2, the fermented extracts of each of Baekbokryeong, Yulmu, and Choseokjab prepared using the Roe-Mung mushroom mycelium and A, B, C, D, and E mixtures prepared according to various mixing ratios When comparing the melanogenesis inhibitory effect of 1), it was confirmed that the melanogenesis inhibitory effect is more significant than the single fermentation extract and A, B, C and E mixture when the 100 and 200 mg / ㎖ D mixture treatment.
실시예Example 5. 5. 백복령Baikyeongryeong , 율무 및 , Law and 초석잠Cornerstone 발효 추출물의 혼합물 처리에 따른 엘라스타아제 및 Elastase according to the mixture treatment of fermented extract and 콜라게나아제Collagenase 활성 저해효과 확인 Confirmation of activity inhibitory effect
(1) 엘라스타아제 활성 저해(1) inhibition of elastase activity
엘라스타아제 저해활성은 다음과 같이 측정하였다. 0.4M의 Tris-HCl 버퍼 (pH 8.6)을 50㎕, 농도별 백복령, 율무 및 초석잠 발효 단독 추출물과 이를 혼합한 혼합물을 50㎕, 50mM의 Tris-HCl 버퍼(pH 8.6)에 0.6 U/ml이 되도록 희석한 효소(ex-porcine pancreas) 50㎕을 넣고 37℃에서 30분간 반응시킨 후 기질(methoxysuccinyl-L-Ala-L-Val-5-nitroanilide)을 100㎕를 넣은 후 37℃에서 30 분간 반응시킨 후 다시 410 nm에서 흡광도를 측정하였다. 그 결과, 도 3에 개시한 바와 같이 노루궁뎅이버섯 균사체를 이용하여 제조한 백복령, 율무 및 초석잠 각각의 발효 추출물과 이를 다양한 혼합 비율에 따라 제조한 A, B, C, D 및 E 혼합물(표 1)들의 엘라스타아제 활성 저해효과를 비교하였을 때, 200㎎/㎖의 D 혼합물 처리시 D 혼합물이 단독 발효 추출물과 A, B, C 및 E 혼합물보다 엘라스타아제 활성을 저해시키는 효과가 통계적으로 유의한 차이가 있다는 것을 확인할 수 있었다.Elastase inhibitory activity was measured as follows. 50 μl of 0.4M Tris-HCl buffer (pH 8.6), the concentrations of Baek-Ryung, Yulmu and Choseok Ferment alone extracts and the mixture of 50 μL Tris-HCl buffer (pH 8.6) in 0.6 U /
(2) (2) 콜라게나아제Collagenase 활성 저해 Activity inhibition
콜라겐은 피부 진피조직을 구성하는 ECM 원섬유 분자(fibrillar molecules)로써 피부의 견고성을 유지시켜주는 역할을 하며 5가지 유형(Ⅰ, Ⅱ, Ⅲ, Ⅳ 및 Ⅴ)이 있는데 콜라겐의 감소는 피부섬유아세포의 합성능 감소 또는 콜라게나아제에 의한 분해능 증가에 의한다. 4mM의 CaCl2를 첨가한 0.1M의 Tris-HCL 버퍼(pH 7.5)에 4-phenylazobenzyloxycarbonyl-Pro-Leu-Gly-Pro-D-Arg(0.3mg/mL)를 녹인 기질액 0.25㎖와 0.25%, 0.5% 및 1%로 희석한 농도별 백복령, 율무 및 초석잠 발효 단독 추출물과 이를 혼합한 혼합물 0.15㎖를 각각 혼합하여 20분간 반응시킨 후 6% 시트르산(citric acid) 0.5㎖을 첨가 후 반응을 정지시키고 에틸 아세테이트 1.5㎖을 첨가하여 원심분리 후 상층액을 취해 320nm에서 흡광도를 측정하였다. 콜라게나아제 저해활성은 시료용액의 첨가군과 무첨가군의 흡광도 감소율로 나타내었다. 그 결과, 도 4에 개시한 바와 같이 노루궁뎅이버섯 균사체를 이용하여 제조한 백복령, 율무 및 초석잠 각각의 발효 추출물과 이를 다양한 혼합 비율에 따라 제조한 A, B, C, D 및 E 혼합물(표 1)들의 콜라게나아제 활성 저해효과를 비교하였을 때, 10㎎/㎖ 처리농도를 제외한 모든 농도의 D 혼합물을 처리한 경우, D 혼합물이 단독 추출물과 A, B, C 및 E 혼합물보다 콜라게나아제 활성 저해효과가 현저하다는 것을 확인할 수 있었다.Collagen is an ECM fibrillar molecule that constitutes the dermal dermal tissue and maintains the firmness of the skin. There are five types (I, II, III, IV and Ⅴ). It is due to the decrease in the synthesis capacity of or increased the resolution by collagenase. 0.25 ml and 0.25% of substrate solution in which 4-phenylazobenzyloxycarbonyl-Pro-Leu-Gly-Pro-D-Arg (0.3 mg / mL) was dissolved in 0.1 M Tris-HCL buffer (pH 7.5) containing 4 mM CaCl 2 . Baekbokryeong, Yulmu, and Choseokjam fermentation alone extracts diluted at 0.5% and 1% and 0.15ml of the mixed mixture were mixed and reacted for 20 minutes, and then 0.5ml of 6% citric acid was added to stop the reaction. 1.5 ml of ethyl acetate was added thereto, followed by centrifugation, and the supernatant was taken and absorbance was measured at 320 nm. Collagenase inhibitory activity was expressed as the absorbance decrease rate of the sample solution addition group and no addition group. As a result, as shown in FIG. 4, the fermented extracts of each of Baekbokryeong, Yulmu, and Choseokjab prepared using the Roe mushroom fungus mycelium and A, B, C, D, and E mixtures prepared according to various mixing ratios (Table When comparing the collagenase activity inhibitory effect of 1), when treated with a mixture of all concentrations of D except 10 mg / ㎖ concentration, the D mixture is a collagenase than a single extract and A, B, C and E mixture It was confirmed that the activity inhibitory effect is remarkable.
Claims (7)
1) 배지 100 중량부에 대하여 7~12 중량부의 백복령, 17~22 중량부의 율무 및 12~17 중량부의 초석잠을 각각 첨가하여 110~130℃에서 10~20분 동안 멸균하는 단계;
2) 상기 단계 1)에서 멸균한 각 재료가 첨가된 배지에 노루궁뎅이버섯 균사체 배양액을 각각 접종하여 24~26℃에서 7~12일 동안 발효하는 단계;
3) 상기 단계 2)에서 획득한 각각의 발효물을 여과하고, 남은 잔여물을 동결건조하는 단계;
4) 상기 단계 3)의 동결건조한 각각의 발효물을 75~85℃에서 열수 추출하여 백복령 발효 추출물, 율무 발효 추출물 및 초석잠 발효 추출물을 획득하는 단계; 및
5) 상기 단계 4)에서 획득한 백복령 발효 추출물, 율무 발효 추출물 및 초석잠 발효 추출물을, 총 100 중량부에 대하여 15~25 중량부의 백복령 발효 추출물, 25~35 중량부의 율무 발효 추출물 및 45~55 중량부의 초석잠 발효 추출물을 혼합하여 혼합물을 제조하는 단계;를 포함하여 제조하는 것을 특징으로 하는 피부 미백 및 주름 개선용 화장료 조성물.According to claim 1, wherein the mixture of Baekbokryeong fermentation extract, Yulmu fermentation extract and choseok nap fermentation extract is
1) sterilizing at 110-130 ° C. for 10-20 minutes by adding 7-12 parts by weight of baekbokyeong, 17-22 parts by weight of yulmu and 12-17 parts by weight of zeolite to 100 parts by weight of medium, respectively;
2) inoculating each of the Roe mushroom fungus mycelium culture medium to each of the ingredients sterilized in step 1) and fermenting at 24 to 26 ℃ for 7 to 12 days;
3) filtering each fermentation product obtained in step 2) and lyophilizing the remaining residue;
4) obtaining each of the lyophilized fermented product of step 3) by hot water extraction at 75-85 ° C. to obtain Baekbokryeong fermentation extract, Yulmu fermentation extract and Choseok fermented fermentation extract; And
5) 15 to 25 parts by weight of Baekbokryeong fermentation extract, jujube fermentation extract and choseokmu fermentation extract obtained in step 4), 15 to 25 parts by weight of Baekbokyeong fermentation extract, 25 to 35 parts by weight of Yulmu fermentation extract and 45 to 55 A step of preparing a mixture by mixing the weight part of salt-free fermentation extract; Cosmetic composition for skin whitening and wrinkle improvement comprising the manufacturing.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020180035957A KR102077708B1 (en) | 2018-03-28 | 2018-03-28 | Composition for skin-whitening and anti-winkle comprising extract of Poria cocos, Coix lachrymajobi and Stachys sieboldii fermented using Hericium erinaceum mycelium as effective component |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020180035957A KR102077708B1 (en) | 2018-03-28 | 2018-03-28 | Composition for skin-whitening and anti-winkle comprising extract of Poria cocos, Coix lachrymajobi and Stachys sieboldii fermented using Hericium erinaceum mycelium as effective component |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20190113371A true KR20190113371A (en) | 2019-10-08 |
KR102077708B1 KR102077708B1 (en) | 2020-02-14 |
Family
ID=68208874
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020180035957A KR102077708B1 (en) | 2018-03-28 | 2018-03-28 | Composition for skin-whitening and anti-winkle comprising extract of Poria cocos, Coix lachrymajobi and Stachys sieboldii fermented using Hericium erinaceum mycelium as effective component |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102077708B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102381645B1 (en) * | 2021-10-18 | 2022-04-01 | 박선규 | Cosmetic Composition Comprising Poria cocos Fermentation Extract |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20100092922A (en) * | 2010-08-03 | 2010-08-23 | 주식회사 세라젬헬스앤뷰티 | A skin whintening cosmetic composition containing a oriental herb extracts mixture stabilized by nanoliposome |
KR20100114673A (en) * | 2009-04-16 | 2010-10-26 | (주)휴럼 | The manufacturing method of fermented aloe for whitening effect in skin, and the functional whitening cosmetics containing fermented aloe |
KR20160024525A (en) * | 2014-08-26 | 2016-03-07 | 한불화장품주식회사 | Cosmetics Compositions Comprising Stachys sieboldii miq. roots Extract as Active Ingredients |
-
2018
- 2018-03-28 KR KR1020180035957A patent/KR102077708B1/en active IP Right Grant
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20100114673A (en) * | 2009-04-16 | 2010-10-26 | (주)휴럼 | The manufacturing method of fermented aloe for whitening effect in skin, and the functional whitening cosmetics containing fermented aloe |
KR20100092922A (en) * | 2010-08-03 | 2010-08-23 | 주식회사 세라젬헬스앤뷰티 | A skin whintening cosmetic composition containing a oriental herb extracts mixture stabilized by nanoliposome |
KR20160024525A (en) * | 2014-08-26 | 2016-03-07 | 한불화장품주식회사 | Cosmetics Compositions Comprising Stachys sieboldii miq. roots Extract as Active Ingredients |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102381645B1 (en) * | 2021-10-18 | 2022-04-01 | 박선규 | Cosmetic Composition Comprising Poria cocos Fermentation Extract |
Also Published As
Publication number | Publication date |
---|---|
KR102077708B1 (en) | 2020-02-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101464745B1 (en) | Compositions comprising fermentative extract of Orchidaceae for improving functions of skin | |
KR101451981B1 (en) | Compositions comprising fermentative extract of Orchidaceae for improving functions of skin | |
KR101971837B1 (en) | Cosmetic composition for improving skin whitening and wrinkle comprising adventitious root extract of Centella asiatica as effective component | |
KR101743200B1 (en) | Composition for skin whitening comprising fraction of fruit extract of Sageretia thea as effective component | |
KR102077708B1 (en) | Composition for skin-whitening and anti-winkle comprising extract of Poria cocos, Coix lachrymajobi and Stachys sieboldii fermented using Hericium erinaceum mycelium as effective component | |
KR20200083293A (en) | Cosmetic composition comprising mixture of fermented extract of Cirsium japonicum and Moringa oleifera | |
KR100981344B1 (en) | The cosmetic composition for preventing the skin aging | |
KR101863895B1 (en) | Composition for skin whitening comprising Stachys sieboldii extract fermented using Hericium erinaceum mycelium as effective component | |
KR101950382B1 (en) | Cosmetic Composition for Whitening of the Skin Comprising Fermented Extracts of Cassia tora, Phragmites communis, Sasa quelpaertensis, Anemarrhena asphodeloides and Gardenia jasminoides Ellis | |
KR101512811B1 (en) | Cosmetic Composition Comprising Reynoutria japonica for. elata Extract for Skin Whitening | |
KR102425559B1 (en) | Composition for improving skin comprising an extract of Pueraria thomsonii or a compound derived therefrom | |
KR102303400B1 (en) | Preparation Methods of Fermentation Products Using JEJU Lava Seawater, JEJU Barley Yeast and Natural Plant and Cosmetic Compositions Having Thereof | |
KR101960571B1 (en) | Method for preparing apricot extract, the apricot extract prepared therefrom, and skin care or cosmetic composition comprising the apricot extract | |
KR100883773B1 (en) | Cosmetic compositions comprising fermenting extracts of citrus junos fruit or poncirus trifoliata fruit with salt | |
KR102471009B1 (en) | Cosmetic composition containing Albiggia kalkora extract for skin whitening and improving wrinkles | |
KR102331214B1 (en) | Cosmetic Composition Containing extract of Pleurotus citrinopileatus and Broussonetia kazinoki branch for anti-aging | |
KR102168533B1 (en) | Cosmetic composition for whitening or improving the facial color containing herb extracts | |
KR20120119520A (en) | Composition for skin external application containing sap of bamboo fermented extracts using bacteria | |
CN113631227A (en) | Antiaging agent, antioxidant, antiinflammatory agent, whitening agent, and cosmetic | |
KR101964837B1 (en) | Composition for improving skin wrinkle comprising Cynomorium songaricum extract or its fraction as effective component | |
KR102154140B1 (en) | Composition comprising tulip leaf extract, amorphophallus paeoniifolius hydrolysis extract and parrot ferment extract | |
KR102356144B1 (en) | Cosmetic composition and health functional food for skin whitening and anti-wrinkle | |
KR102525129B1 (en) | Composition comprising fermented extracts of unripe plum and manufacturing method thereof | |
KR102393811B1 (en) | Composition comprising for whitening of skin containing fermented solution | |
KR102644047B1 (en) | A composition for preventing or improving skin wrinkles or skin thermal aging comprising rosa multiflora extracts |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |